Pages that link to "Q35149263"
Jump to navigation
Jump to search
The following pages link to Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease. (Q35149263):
Displaying 32 items.
- Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication (Q26745972) (← links)
- Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer (Q28077032) (← links)
- Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2 (Q28386917) (← links)
- The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data (Q31038314) (← links)
- Prognostic significance of SOX2 in head and neck cancer: a meta-analysis (Q35017036) (← links)
- KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas (Q35751428) (← links)
- Prognostic significance of SOX-1 expression in human hepatocelluar cancer. (Q35854187) (← links)
- Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. (Q35896945) (← links)
- SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling (Q36184138) (← links)
- The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis (Q36450685) (← links)
- The chromosome 3q26 OncCassette: A multigenic driver of human cancer (Q36510237) (← links)
- SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma (Q36548775) (← links)
- The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer (Q36857674) (← links)
- Squamous Cell Cancers: A Unified Perspective on Biology and Genetics (Q36909843) (← links)
- Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis (Q37376323) (← links)
- Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells (Q37720250) (← links)
- SOX2 and cancer: current research and its implications in the clinic (Q38239137) (← links)
- Pluripotency transcription factors in lung cancer-a review. (Q38637870) (← links)
- MiR-429 suppresses glioblastoma multiforme by targeting SOX2. (Q38696293) (← links)
- Kinase gene fusions in defined subsets of melanoma (Q39172703) (← links)
- SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas (Q43201485) (← links)
- SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. (Q48157807) (← links)
- Identification of genomic copy number variations associated with specific clinical features of head and neck cancer (Q48162253) (← links)
- Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo. (Q51075761) (← links)
- Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage. (Q53176607) (← links)
- OCT4, SOX2, and NAN OG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2 + breast cancer patients (Q59135024) (← links)
- FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer (Q88955678) (← links)
- The association between fibroblast growth factor receptor 1 gene amplification and lung cancer: a meta-analysis (Q89687370) (← links)
- Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer (Q89857370) (← links)
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells (Q90639806) (← links)
- Downregulation of SOX2 may be targeted by miR-590-5p and inhibits epithelial-to-mesenchymal transition in non-small-cell lung cancer (Q91972644) (← links)
- Functional characterization of SOX2 as an anticancer target (Q98164349) (← links)